New Osteoarthritis Study Shows Most Treatments Do Not Work Meta-analysis calls into question the premises underlying classic osteoarthritis treatment guidelines Despite the billions of euros spent on osteoarthritis treatments in Germany, the effectiveness of those treatments remains highly controversial among experts.
Source: www.medicalnewstoday.comThe European Medicines Agency Recommends Suspension Of The Marketingauthorisation Of Acomplia The European
Medicines Agency (EMEA) has recommended the suspension of the marketing authorisation for Acomplia (rimonabant) from Sanofi-Aventis. The EMEA's Committee for Medicinal Products for Human Use (CHMP) has concluded that the benefits of Acomplia no longer outweigh its risks and the marketing authorisation should be suspended across the European Union (EU).
Source: www.medicalnewstoday.comAustralian Stroke Study: Research Could Save Lives And Millions Of Dollars The Hunter Medical Research Institute (HMRI) Stroke Research Group has developed a system to fast track stroke treatment which could benefit thousands of Australian stroke patients and save millions of dollars annually.
Source: www.medicalnewstoday.comCrohn's Disease - Neovacs Begins A Phase I/II Clinical Trial With Candidate TNFα-kinoid, First Phase I/II Human Study Of A Kinoid Neovacs, a leading biotechnology company in the development of anti-cytokine and anti-protein viral regulation therapeutic vaccines to treat certain cancers and inflammatory diseases, announced that it had begun a phase I/II clinical study at three study centres in South Africa with the candidate TNF
Source: www.medicalnewstoday.com
# posted by Network @ 6:00 AM
